The global clinical perinatal software market was valued at USD 375.73 million in 2025 and is projected to grow from USD 406.2 million in 2026 to USD 989.3 million by 2034, registering a robust CAGR of 11.77% during the forecast period. This growth is primarily driven by the rising global burden of maternal and neonatal health, rapid digitalization of hospital systems, and increasing adoption of electronic health records (EHR) and real-time clinical monitoring tools.
Source: Fortune Business Insights – Clinical Perinatal Software Market
Clinical perinatal software refers to specialized digital platforms used in maternal-fetal and neonatal care settings. These tools support healthcare systems in managing pregnancy, labor and delivery, and newborn care by integrating clinical data, monitoring maternal and fetal conditions, and improving decision-making throughout the perinatal care continuum.
The most significant driver for this market is the increasing burden of maternal and neonatal health globally. According to a WHO report published in April 2025, approximately 260,000 women died from pregnancy and childbirth-related causes in 2023, with low- and middle-income countries accounting for around 90% of these deaths. Clinical perinatal software helps reduce such mortality through real-time monitoring of premature infants, early detection of complications, and timely clinical interventions.
Additionally, the integration of telehealth and remote monitoring is emerging as a major growth opportunity. The COVID-19 pandemic significantly accelerated the adoption of hybrid prenatal care models, combining in-person visits with digital consultations. A study published in NCBI noted that around 17.3% of participants had a telehealth prenatal visit in November 2020, compared to just 1% before January 2020.
Limited adoption in emerging economies remains a key restraint. Infrastructure gaps, high costs, and a shortage of trained healthcare personnel slow deployment outside developed markets. High implementation costs also pose a significant challenge, particularly for smaller hospitals, specialty clinics, and healthcare facilities in low- and middle-income countries.
A notable trend reshaping the market is the shift toward cloud-based and SaaS models. Hospitals are increasingly migrating to cloud platforms due to their cost efficiency, scalability, and remote accessibility. The cloud-based segment is expected to grow at a CAGR of 13.93% over the forecast period.
North America dominated the global market with a 41.32% share in 2025, valued at USD 155.25 million, driven by high maternal mortality rates, strong digital health adoption, and favorable regulatory frameworks. Europe held the second position at USD 92.82 million (24.70% share). Asia Pacific generated USD 84.98 million in 2025 and is expanding rapidly due to improving healthcare infrastructure and rising birth rates.
Q1. What is the size and share of the clinical perinatal software market? The global clinical perinatal software market was valued at USD 375.73 million in 2025 and is projected to reach USD 989.3 million by 2034, growing at a CAGR of 11.77%. North America held the leading regional share at 41.32% in 2025.
Q2. What factors are driving growth in the clinical perinatal software market? Key growth drivers include the rising global burden of maternal and neonatal mortality, increasing digitalization of hospitals, growing adoption of EHR systems, supportive government policies for digital health, and expanding integration of telehealth and AI-based monitoring solutions.
Q3. Which application segment leads the clinical perinatal software market? The fetal monitoring segment holds the largest application share at 36.74% in 2026. Its widespread clinical use in detecting abnormal fetal heart rate patterns and preventing complications such as intrapartum hypoxia and preterm distress drives its dominant position.